A citation-based method for searching scientific literature

Ian R McGrane, Joshua G Loveland. J Child Adolesc Psychopharmacol 2016
Times Cited: 7







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects.
M L Dahl, Q Y Yue, H K Roh, I Johansson, J Säwe, F Sjöqvist, L Bertilsson. Pharmacogenetics 1995
92
28

Clinical applications of CYP genotyping in psychiatry.
Edoardo Spina, Jose de Leon. J Neural Transm (Vienna) 2015
89
28

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.
Gideon Koren, James Cairns, David Chitayat, Andrea Gaedigk, Steven J Leeder. Lancet 2006
391
28

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
768
28



Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.
Stacey L Aldrich, Ethan A Poweleit, Cynthia A Prows, Lisa J Martin, Jeffrey R Strawn, Laura B Ramsey. Front Pharmacol 2019
39
28

The Evolution of PharmVar.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Greyson P Twist, Teri E Klein, Neil A Miller. Clin Pharmacol Ther 2019
67
28

Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Chad Bousman, Abdullah Al Maruf, Daniel J Müller. Curr Opin Psychiatry 2019
37
28

CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
Fernando de Andrés, Martha Sosa-Macías, Blanca Patricia Lazalde Ramos, María-Eugenia G Naranjo, Adrián LLerena. OMICS 2017
19
14

Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.
Alison E Fohner, Renee Robinson, Joseph Yracheta, Denise A Dillard, Brian Schilling, Burhan Khan, Scarlett Hopkins, Bert Boyer, Jynene Black, Howard Wiener,[...]. Pharmacogenet Genomics 2015
26
14


Effect of the cytochrome P-450IIE1 genotype on ethanol elimination rate in alcoholics and control subjects.
Y Ueno, J Adachi, H Imamichi, A Nishimura, Y Tatsuno. Alcohol Clin Exp Res 1996
26
14

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
P Kuehl, J Zhang, Y Lin, J Lamba, M Assem, J Schuetz, P B Watkins, A Daly, S A Wrighton, S D Hall,[...]. Nat Genet 2001
14

Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
E Störmer, L L von Moltke, R I Shader, D J Greenblatt. Drug Metab Dispos 2000
90
14

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
T Andersson, C G Regårdh, M L Dahl-Puustinen, L Bertilsson. Ther Drug Monit 1990
183
14


Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations.
Osvaldo D Castelán-Martínez, Carlos Hoyo-Vadillo, Emmanuel Sandoval-García, Lucila Sandoval-Ramírez, Miriam González-Ibarra, Gloria Solano-Solano, Rita A Gómez-Díaz, Esteban J Parra, Miguel Cruz, Adán Valladares-Salgado. Gene 2013
19
14

Genetic contribution to variable human CYP3A-mediated metabolism.
Jatinder K Lamba, Yvonne S Lin, Erin G Schuetz, Kenneth E Thummel. Adv Drug Deliv Rev 2002
722
14

Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population.
Nicholas T Au, Morayma Reyes, Bert B Boyer, Scarlett E Hopkins, Jynene Black, Diane O'Brien, Alison E Fohner, Joe Yracheta, Timothy Thornton, Melissa A Austin,[...]. PLoS One 2017
4
25

Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans.
W E Evans, M V Relling, A Rahman, H L McLeod, E P Scott, J S Lin. J Clin Invest 1993
99
14

Human cytochromes mediating N-demethylation of fluoxetine in vitro.
L L von Moltke, D J Greenblatt, S X Duan, J Schmider, C E Wright, J S Harmatz, R I Shader. Psychopharmacology (Berl) 1997
72
14

Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15.
N K Spurr, A C Gough, K Stevenson, C R Wolf. Nucleic Acids Res 1987
64
14




Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
274
14

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
Matthew G McDonald, Mark J Rieder, Mariko Nakano, Clara K Hsia, Allan E Rettie. Mol Pharmacol 2009
214
14

Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
L Poulsen, K Brøsen, L Arendt-Nielsen, L F Gram, K Elbaek, S H Sindrup. Eur J Clin Pharmacol 1996
173
14


The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.
Laure Elens, Rachida Bouamar, Dennis A Hesselink, Vincent Haufroid, Teun van Gelder, Ron H N van Schaik. Pharmacogenet Genomics 2012
67
14

Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Elaine Johnstone, Neal Benowitz, Anna Cargill, Robyn Jacob, Lesley Hinks, Ian Day, Mike Murphy, Robert Walton. Clin Pharmacol Ther 2006
100
14

Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.
J S Miles, A W McLaren, L M Forrester, M J Glancey, M A Lang, C R Wolf. Biochem J 1990
199
14

Nicotine dependence: biology, behavior, and treatment.
Riju Ray, Robert A Schnoll, Caryn Lerman. Annu Rev Med 2009
33
14

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
T Andersson, J O Miners, M E Veronese, D J Birkett. Br J Clin Pharmacol 1994
192
14

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities.
S A Ward, T Walle, U K Walle, G R Wilkinson, R A Branch. Clin Pharmacol Ther 1989
193
14

Functional significance of different human CYP1A1 genotypes.
F Crofts, E Taioli, J Trachman, G N Cosma, D Currie, P Toniolo, S J Garte. Carcinogenesis 1994
286
14

CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients.
Wei Zhang, Yan-Zi Chang, Quan-Cheng Kan, Li-Rong Zhang, Zhi-Song Li, Hui Lu, Zhong-Yu Wang, Qin-Jun Chu, Jie Zhang. Eur J Clin Pharmacol 2010
63
14

Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities.
B B Boyer, D Dillard, E L Woodahl, R Whitener, K E Thummel, W Burke. Clin Pharmacol Ther 2011
30
14


Predicting in vivo drug interactions from in vitro drug discovery data.
Larry C Wienkers, Timothy G Heath. Nat Rev Drug Discov 2005
563
14

Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
U Fuhr, S Kober, M Zaigler, E Mutschler, H Spahn-Langguth. Int J Clin Pharmacol Ther 2005
9
14

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
Edward M Sellers, Yamini Ramamoorthy, Marilyn V Zeman, Mirjana V Djordjevic, Rachel F Tyndale. Nicotine Tob Res 2003
50
14


Biochemistry and molecular biology of the human CYP2C subfamily.
J A Goldstein, S M de Morais. Pharmacogenetics 1994
457
14


Population description and its role in the interpretation of genetic association.
Stephanie M Fullerton, Joon-Ho Yu, Julia Crouch, Kelly Fryer-Edwards, Wylie Burke. Hum Genet 2010
13
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.